We are live on ! Find out more
PM

Ponoi Management Portfolio holdings

AUM $73.2M
1-Year Est. Return 23.44%
This Fund
S&P 500
This Quarter Est. Return
-24.66%
1 Year Est. Return
-23.44%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$77M
AUM Growth
-$31.4M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAPT
1
DELISTED
RAPT Therapeutics
RAPT
$35.2M 45.65%
199,927
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$19.8M 25.71%
1,298,908
RVMD icon
3
Revolution Medicines
RVMD
$47.4B
$17.5M 22.68%
685,011
NRIX icon
4
Nurix Therapeutics
NRIX
$2.79B
$4.58M 5.95%
327,122

Similar funds

Ponoi Management's Q1 2022 Portfolio in Review

As of Q1 2022, Ponoi Management held 4 positions worth $77M, down 29% from $108M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0%. Ponoi Management opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Ponoi Management's ten largest holdings make up 100% of its $77M portfolio in Q1 2022.
  • Ponoi Management opened 0 new positions and closed 0 in Q1 2022.
  • Ponoi Management's portfolio value fell 29% quarter-over-quarter to $77M.

Based on Ponoi Management's 13F filing for Q1 2022, filed 16 May 2022.